Show simple item record

CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

dc.contributor.authorTüzün, Erdem
dc.contributor.authorUlusoy, Canan Aysel
dc.contributor.authorEraksoy, Mefküre
dc.contributor.authorYılmaz, Vuslat
dc.contributor.authorGündüz, Tuncay
dc.contributor.authorKaraaslan, Zerrin
dc.contributor.authorKürtüncü, Murat
dc.contributor.authorAkçay, Halil İbrahim
dc.contributor.authorAltunrende, Burcu
dc.contributor.authorTürkoğlu, Recai
dc.date.accessioned2021-12-10T09:57:37Z
dc.date.available2021-12-10T09:57:37Z
dc.identifier.citationKaraaslan Z., Kürtüncü M., Akçay H. İ. , Gündüz T., Altunrende B., Türkoğlu R., Eraksoy M., Ulusoy C. A. , Yılmaz V., Tüzün E., "CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients", European Neurology, cilt.2, ss.1-3, 2021
dc.identifier.issn0014-3022
dc.identifier.othervv_1032021
dc.identifier.otherav_1f31487f-93f3-4db3-af71-7cddcc63dc73
dc.identifier.urihttp://hdl.handle.net/20.500.12627/168881
dc.identifier.urihttps://www.karger.com/Article/FullText/517770
dc.identifier.urihttps://doi.org/10.1159/000517770
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleCXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
dc.typeMakale
dc.relation.journalEuropean Neurology
dc.contributor.departmentİstanbul Üniversitesi , Aziz Sancar Deneysel Tıp Araştırma Enstitüsü , Sinir Bilimi Ana Bilim Dalı
dc.identifier.volume2
dc.identifier.startpage1
dc.identifier.endpage3
dc.contributor.firstauthorID2696902


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record